These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 25933971)

  • 1. Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism.
    Smaga I; Niedzielska E; Gawlik M; Moniczewski A; Krzek J; Przegaliński E; Pera J; Filip M
    Pharmacol Rep; 2015 Jun; 67(3):569-80. PubMed ID: 25933971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 1. Chemical aspects and biological sources of oxidative stress in the brain.
    Moniczewski A; Gawlik M; Smaga I; Niedzielska E; Krzek J; Przegaliński E; Pera J; Filip M
    Pharmacol Rep; 2015 Jun; 67(3):560-8. PubMed ID: 25933970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative Stress in Neurodegenerative Diseases.
    Niedzielska E; Smaga I; Gawlik M; Moniczewski A; Stankowicz P; Pera J; Filip M
    Mol Neurobiol; 2016 Aug; 53(6):4094-4125. PubMed ID: 26198567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 25-methoxy hispidol A isolated from Poncirus trifoliate against bacteria-induced anxiety and depression by targeting neuroinflammation, oxidative stress and apoptosis in mice.
    Shal B; Khan A; Naveed M; Ullah Khan N; Ihsan-Ul-Haq ; D AlSharari S; Kim YS; Khan S
    Biomed Pharmacother; 2019 Mar; 111():209-223. PubMed ID: 30583228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of supplementary vitamins C and E on anxiety, depression and stress in type 2 diabetic patients: a randomized, single-blind, placebo-controlled trial.
    Mazloom Z; Ekramzadeh M; Hejazi N
    Pak J Biol Sci; 2013 Nov; 16(22):1597-600. PubMed ID: 24511708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mini-review: Brain energy metabolism and its role in animal models of depression, bipolar disorder, schizophrenia and autism.
    Kolar D; Kleteckova L; Brozka H; Vales K
    Neurosci Lett; 2021 Aug; 760():136003. PubMed ID: 34098028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress and therapeutic implications in psychiatric disorders.
    Zhang XY; Yao JK
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():197-9. PubMed ID: 23523744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial dysfunction and psychiatric disorders.
    Rezin GT; Amboni G; Zugno AI; Quevedo J; Streck EL
    Neurochem Res; 2009 Jun; 34(6):1021-9. PubMed ID: 18979198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications.
    Ng F; Berk M; Dean O; Bush AI
    Int J Neuropsychopharmacol; 2008 Sep; 11(6):851-76. PubMed ID: 18205981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations.
    Prata J; Santos SG; Almeida MI; Coelho R; Barbosa MA
    J Neuroinflammation; 2017 Sep; 14(1):179. PubMed ID: 28870209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perinatal inflammation and adult psychopathology: From preclinical models to humans.
    Depino AM
    Semin Cell Dev Biol; 2018 May; 77():104-114. PubMed ID: 28890420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress in anxiety and comorbid disorders.
    Hovatta I; Juhila J; Donner J
    Neurosci Res; 2010 Dec; 68(4):261-75. PubMed ID: 20804792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric aspects of phosphodiesterases: An overview.
    Murthy VS; Mangot AG
    Indian J Pharmacol; 2015; 47(6):594-9. PubMed ID: 26729948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant treatments for schizophrenia.
    Magalhães PV; Dean O; Andreazza AC; Berk M; Kapczinski F
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008919. PubMed ID: 26848926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of oxidative stress in the pathophysiology of neuropsychiatric disorders].
    Nunomura A; Tamaoki T; Motohashi N
    Seishin Shinkeigaku Zasshi; 2014; 116(10):842-58. PubMed ID: 25672211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidation-reduction mechanisms in psychiatric disorders: A novel target for pharmacological intervention.
    Rossetti AC; Paladini MS; Riva MA; Molteni R
    Pharmacol Ther; 2020 Jun; 210():107520. PubMed ID: 32165136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The basis for folinic acid treatment in neuro-psychiatric disorders.
    Ramaekers VT; Sequeira JM; Quadros EV
    Biochimie; 2016 Jul; 126():79-90. PubMed ID: 27068282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oxidative stress involvement in schizophrenia pathophysiology: a review].
    Fendri C; Mechri A; Khiari G; Othman A; Kerkeni A; Gaha L
    Encephale; 2006; 32(2 Pt 1):244-52. PubMed ID: 16910626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-depressant and anxiolytic potential of Acacia hydaspica R. Parker aerial parts extract: Modulation of brain antioxidant enzyme status.
    Afsar T; Razak S; Khan MR; Almajwal A
    BMC Complement Altern Med; 2017 Apr; 17(1):228. PubMed ID: 28438149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric Disorders and Polyphenols: Can They Be Helpful in Therapy?
    Trebatická J; Ďuračková Z
    Oxid Med Cell Longev; 2015; 2015():248529. PubMed ID: 26180581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.